BrightSpring Health Services, Inc. BTSG
56.59
0.57
1.02%
as of 25 Sep
- Market cap
- $11.1B
- P/E
- 31.6×
Follow BTSG
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
46.19 | 39.84 | 28.03 | 38.96 |
P/S ratio |
0.50 | 0.59 | 0.64 | 1.00 | |
P/FCF ratio |
21.79 | 19.22 | 21.17 | 35.71 | |
P/Operating CF |
55.73 | 32.76 | 70.95 | 327.20 | |
P/B ratio |
3.31 | 4.05 | 4.41 | 7.01 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.69 | 0.78 | 0.76 | 1.11 | |
EV/EBITDA |
19.39 | 21.28 | 19.21 | 25.84 | |
EV/Operating CF |
24.06 | 20.44 | 20.22 | 31.64 | |
EV/FCF |
30.43 | 25.39 | 25.10 | 39.82 | |
Quick Ratio |
0.74 | 0.58 | 1.29 | 1.09 | |
Current Ratio |
1.79 | 1.57 | 1.74 | 1.59 | |
Net Debt/EBITDA |
18.16 | 16.17 | 9.93 | 9.46 | |
Debt/Assets |
41.78% | 39.33% | 40.41% | 36.82% | |
Debt/Equity |
1.39 | 1.35 | 1.27 | 1.08 | |
Asset Turnover |
2.05 | 2.09 | 2.26 | 2.41 | |
Operating CF/Net income |
1.93 | 3.00 | 0.83 | 0.52 | |
Capex/Depreciation |
(0.36) | (0.89) | (0.51) | (0.65) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.12% | 8.57% | 9.98% | 9.36% | |
Intangible Assets out of Total Assets |
0.48 | 0.48 | 0.49 | 0.51 | |
Share Based Compensation of Revenue |
0.52% | 0.40% | 0.10% | 0.50% | |
Graham Net Nets |
(0.24) | (0.22) | (0.18) | (0.10) | |
Graham Number |
11.34 | 13.99 | 18.18 | 20.01 | |
Earnings Yield |
2.17% | 2.51% | 3.57% | 2.57% | |
Free Cash Flow Yield |
4.59% | 5.20% | 4.72% | 2.80% | |
Revenue per Share |
16.38 | 17.53 | 17.65 | 18.80 | |
Operating CF per Share |
0.53 | 1.14 | 0.60 | 0.21 | |
Capex per Share |
(0.08) | (0.19) | (0.11) | (0.14) | |
Free Cash Flow per Share |
0.45 | 0.96 | 0.50 | 0.07 | |
Cash per Share |
0.69 | 0.44 | 4.34 | 2.67 | |
Shareholders Equity per Share |
8.94 | 9.26 | 9.67 | 9.94 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.94 | 9.26 | 9.67 | 9.94 | |
Free Cash Flow |
92.17 | 193.89 | 101.40 | 14.88 | |
Working Capital |
1,230.31 | 1,045.02 | 1,140.89 | 914.34 | |
Capital Expenditures |
(15.76) | (37.66) | (21.54) | (29.03) | |
Net Current Asset Value |
(1,450.56) | (1,644.12) | (1,544.63) | (1,466.96) | |
EV/EBIT |
34.62 | 33.94 | 28.27 | 35.78 | |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
1.67% | 2.17% | 4.12% | 2.18% | |
Price to Operating Income |
24.79 | 25.69 | 23.84 | 32.09 | |
| Other line items | |||||
Average Receivables |
1,019.31 | 946.25 | 1,044.40 | 1,056.07 | |
Average Payables |
869.17 | 1,070.94 | 979.76 | 1,028.11 | |
Average Inventory |
558.76 | 725.87 | 546.90 | 600.24 | |
Average Assets |
5,917.73 | 6,169.73 | 6,030.13 | 5,964.66 | |
Average Common Equity |
1,716.81 | 1,761.50 | 1,833.31 | 1,895.70 |
Columns are period end dates